The Prevention of Hospital Readmissions in Heart Failure

Overview

Journal Prog Cardiovasc Dis

Specialty Cardiology & Vascular Diseases

Date 2015 Oct 4

PMID 26432556

Citations 83

Authors

Boback Ziaeian

Gregg C Fonarow

Affiliations

Soon will be listed here.

Abstract

Heart failure (HF) is a growing healthcare burden and one of the leading causes of hospitalizations and readmission. Preventing readmissions for HF patients is an increasing priority for clinicians, researchers, and various stakeholders. The following review will discuss the interventions found to reduce readmissions for patients and improve hospital performance on the 30-day readmission process measure. While evidence-based therapies for HF management have proliferated, the consistent implementation of these therapies and development of new strategies to more effectively prevent readmissions remain areas for continued improvement.

Citing Articles

Social Determinants of Health and 30-Day Readmission After Acute Myocardial Infarction in the REGARDS Study.

Amankwah K, Soroka O, Pinheiro L, Sterling M, Amankwah E, Almarzooq Z JACC Adv. 2025; 4(3):101584.

PMID: 39951935 PMC: 11875161. DOI: 10.1016/j.jacadv.2025.101584.

Incidence, timing and variation in unplanned readmissions within 30-days following isolated coronary artery bypass grafting.

Patel A, Khawaja S, Dang T, Ranasinghe I Int J Cardiol Heart Vasc. 2024; 56:101552.

PMID: 39687688 PMC: 11647132. DOI: 10.1016/j.ijcha.2024.101552.

Reducing rehospitalization in cardiac patients: a randomized, controlled trial of a cardiac care management program ("Cardiolotse") in Germany.

Schuttig W, Darius H, Reber K, Coors M, Flothow A, Holzgreve A BMC Med. 2024; 22(1):480.

PMID: 39428539 PMC: 11492482. DOI: 10.1186/s12916-024-03691-7.

Improving TRansitions ANd outcomeS for heart FailurE patients in home health CaRe (I-TRANSFER-HF): a type 1 hybrid effectiveness-implementation trial: study protocol.

Sterling M, Espinosa C, Spertus D, Shum M, McDonald M, Ryvicker M BMC Health Serv Res. 2024; 24(1):1160.

PMID: 39354472 PMC: 11443790. DOI: 10.1186/s12913-024-11584-x.

A Need to Preserve Ejection Fraction during Heart Failure.

Akinterinwa O, Singh M, Vemuri S, Tyagi S Int J Mol Sci. 2024; 25(16).

PMID: 39201469 PMC: 11354382. DOI: 10.3390/ijms25168780.

References

Hernandez A, Hammill B, OConnor C, Schulman K, Curtis L, Fonarow G . Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol. 2009; 53(2):184-92. PMC: 3513266. DOI: 10.1016/j.jacc.2008.09.031. View

Krumholz H, Amatruda J, Smith G, Mattera J, Roumanis S, Radford M . Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002; 39(1):83-9. DOI: 10.1016/s0735-1097(01)01699-0. View

Phillips C, Wright S, Kern D, Singa R, Shepperd S, Rubin H . Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA. 2004; 291(11):1358-67. DOI: 10.1001/jama.291.11.1358. View

Sperry B, Ruiz G, Najjar S . Hospital readmission in heart failure, a novel analysis of a longstanding problem. Heart Fail Rev. 2014; 20(3):251-8. DOI: 10.1007/s10741-014-9459-2. View

Masoudi F, Mi X, Curtis L, Peterson P, Curtis J, Fonarow G . Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Ann Intern Med. 2014; 160(9):603-11. DOI: 10.7326/M13-1879. View

Hernandez A, Mi X, Hammill B, Hammill S, Heidenreich P, Masoudi F . Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction. JAMA. 2012; 308(20):2097-107. DOI: 10.1001/jama.2012.14795. View

Nagasako E, Reidhead M, Waterman B, Dunagan W . Adding socioeconomic data to hospital readmissions calculations may produce more useful results. Health Aff (Millwood). 2014; 33(5):786-91. PMC: 4079850. DOI: 10.1377/hlthaff.2013.1148. View

Bhalla R, Kalkut G . Could Medicare readmission policy exacerbate health care system inequity?. Ann Intern Med. 2009; 152(2):114-7. DOI: 10.7326/0003-4819-152-2-201001190-00185. View

Gattis W, OConnor C, Gallup D, Hasselblad V, Gheorghiade M . Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol. 2004; 43(9):1534-41. DOI: 10.1016/j.jacc.2003.12.040. View

10.

Dharmarajan K, Hsieh A, Lin Z, Bueno H, Ross J, Horwitz L . Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013; 309(4):355-63. PMC: 3688083. DOI: 10.1001/jama.2012.216476. View

11.

Hansen L, Young R, Hinami K, Leung A, Williams M . Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011; 155(8):520-8. DOI: 10.7326/0003-4819-155-8-201110180-00008. View

12.

van Walraven C, Jennings A, Forster A . A meta-analysis of hospital 30-day avoidable readmission rates. J Eval Clin Pract. 2011; 18(6):1211-8. DOI: 10.1111/j.1365-2753.2011.01773.x. View

13.

Bradley E, Curry L, Horwitz L, Sipsma H, Wang Y, Walsh M . Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013; 6(4):444-50. PMC: 3802532. DOI: 10.1161/CIRCOUTCOMES.111.000101. View

14.

McHugh M, Berez J, Small D . Hospitals with higher nurse staffing had lower odds of readmissions penalties than hospitals with lower staffing. Health Aff (Millwood). 2013; 32(10):1740-7. PMC: 4315496. DOI: 10.1377/hlthaff.2013.0613. View

15.

Chaudhry S, Mattera J, Curtis J, Spertus J, Herrin J, Lin Z . Telemonitoring in patients with heart failure. N Engl J Med. 2010; 363(24):2301-9. PMC: 3237394. DOI: 10.1056/NEJMoa1010029. View

16.

Joynt K, Orav E, Jha A . The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure. Ann Intern Med. 2011; 154(2):94-102. PMC: 3336194. DOI: 10.7326/0003-4819-154-2-201101180-00008. View

17.

Krumholz H, Lin Z, Keenan P, Chen J, Ross J, Drye E . Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA. 2013; 309(6):587-93. PMC: 3621028. DOI: 10.1001/jama.2013.333. View

18.

Bhatia R, Austin P, Stukel T, Schull M, Chong A, Tu J . Outcomes in patients with heart failure treated in hospitals with varying admission rates: population-based cohort study. BMJ Qual Saf. 2014; 23(12):981-8. PMC: 4255669. DOI: 10.1136/bmjqs-2014-002816. View

19.

Packer M, Bristow M, Cohn J, Colucci W, Fowler M, Gilbert E . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996; 334(21):1349-55. DOI: 10.1056/NEJM199605233342101. View

20.

Pitt B, Zannad F, Remme W, Cody R, CASTAIGNE A, Perez A . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341(10):709-17. DOI: 10.1056/NEJM199909023411001. View